Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.

Slaton, Joel W; Unger, Gretchen M; Sloper, Daniel T; Davis, Alan T; Ahmed, Khalil

Slaton, Joel W; Unger, Gretchen M; Sloper, Daniel T; Davis, Alan T; Ahmed, Khalil.

Affiliation

Slaton JW; Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.

Mol Cancer Res ; 2(12): 712-21, 2004 Dec.

Article in En | MEDLINE | ID: mdl-15634760

Subject(s)

Casein Kinase II/genetics; Casein Kinase II/pharmacology; Oligonucleotides, Antisense; Prostatic Neoplasms/pathology; Animals; Apoptosis; Cell Line, Tumor; Cell Nucleus/metabolism; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Humans; In Situ Hybridization, Fluorescence; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligonucleotides, Antisense/chemistry; Oligonucleotides, Antisense/pharmacology; Prostate/metabolism; RNA, Messenger/metabolism; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Oligonucleotides, Antisense / Casein Kinase II Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Mol Cancer Res Year: 2004 Document type: Article

Search on Google

XML

PubMed Links